NDC 55513-180 – Bkemv

Eculizumab 300 mg/30mL · Injection, Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC55513-180

Product details

Brand name
Bkemv
Generic name
Eculizumab-aeeb
Labeler
Amgen Inc
Dosage form
Injection, Solution, Concentrate
Route
Intravenous
Marketing category
BLA · BLA761333
Marketed since
March 1, 2025
Listing expires
December 31, 2027
Pharmacologic class
Complement Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Bkemv →

Package NDC codes (1)

Package NDCDescriptionSince
55513-180-011 VIAL in 1 CARTON (55513-180-01) / 30 mL in 1 VIALMar 1, 2025